microRNA-29c and microRNA-223 down-regulation has in vivo significance in chronic lymphocytic leukemia and improves disease risk stratification

A study of pre-validation

(2008) Holger Höfling et al.   Annals of Applied Statistics

Mcl-1 expression has in vitro and in vivo significance in chronic lymphocytic leukemia and is associated with other poor prognostic markers

(2008) C. Pepper et al.   BLOOD

New prognostic markers in chronic lymphocytic leukemia

(2008) Carol Moreno et al.   BLOOD REVIEWS

Prognostic markers in chronic lymphocytic leukemia: A comprehensive review

(2008) Femke Van Bockstaele et al.   BLOOD REVIEWS

CD49d expression is an independent predictor of overall survival in patients with chronic lymphocytic leukaemia: a prognostic parameter with therapeutic potential

(2008) Tait D. Shanafelt et al.   BRITISH JOURNAL OF HAEMATOLOGY

Stathmin 1: a novel therapeutic target for anticancer activity

(2008) Shushan Rana et al.   Expert Review of Anticancer Therapy

Doubling time of soluble CD23: a powerful prognostic factor for newly diagnosed and untreated stage A chronic lymphocytic leukemia patients

(2008) N Meuleman et al.   LEUKEMIA

MicroRNAs and noncoding RNAs in hematological malignancies: molecular, clinical and therapeutic implications

(2008) M Fabbri et al.   LEUKEMIA

Regulation of progenitor cell proliferation and granulocyte function by microRNA-223

(2008) Jonathan B. Johnnidis et al.   NATURE

MicroRNA 29c is down-regulated in nasopharyngeal carcinomas, up-regulating mRNAs encoding extracellular matrix proteins

(2008) S. Sengupta et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA